These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18281378)

  • 1. Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women.
    Meendering JR; Torgrimson BN; Miller NP; Kaplan PF; Minson CT
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1630-7. PubMed ID: 18281378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depot-medroxyprogesterone acetate and endothelial function before and after acute oral, vaginal, and transdermal estradiol treatment.
    Torgrimson BN; Meendering JR; Kaplan PF; Minson CT
    Hypertension; 2011 Apr; 57(4):819-24. PubMed ID: 21357271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of medroxyprogesterone acetate plus estradiol on endothelium-dependent vasodilation in postmenopausal women.
    Kawano H; Motoyama T; Hirai N; Yoshimura T; Kugiyama K; Ogawa H; Okamura H; Yasue H
    Am J Cardiol; 2001 Jan; 87(2):238-40, A9. PubMed ID: 11152852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women.
    Miner JA; Martini ER; Smith MM; Brunt VE; Kaplan PF; Halliwill JR; Minson CT
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1716-22. PubMed ID: 21856917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient acceptability and satisfaction with Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension).
    Shulman LP; Oleen-Burkey M; Willke RJ
    Contraception; 1999 Oct; 60(4):215-22. PubMed ID: 10640168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.
    Torgrimson BN; Meendering JR; Kaplan PF; Minson CT
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2874-80. PubMed ID: 17277029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
    Rahimy MH; Ryan KK
    Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.
    Gerhard M; Walsh BW; Tawakol A; Haley EA; Creager SJ; Seely EW; Ganz P; Creager MA
    Circulation; 1998 Sep; 98(12):1158-63. PubMed ID: 9743505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ET
    Shoemaker LN; Haigh KM; Kuczmarski AV; McGinty SJ; Welti LM; Hobson JC; Edwards DG; Feinberg RF; Wenner MM
    Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H592-H598. PubMed ID: 34415188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
    Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM
    Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasomotor and vascular effects of hormone replacement therapy.
    Ganz P
    Am J Cardiol; 2002 Jul; 90(1A):11F-16F. PubMed ID: 12106634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medroxyprogesterone acetate does not antagonize estrogen-induced increases in endothelium-dependent vasodilation: potential clinical implications.
    Dinh H; Nathan L
    Fertil Steril; 2002 Jul; 78(1):122-7. PubMed ID: 12095501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic) on lipid profiles. Investigators from the Lunelle Study Group.
    Cromie MA; Maile MH; Wajszczuk CP
    Contraception; 2000 Jan; 61(1):51-9. PubMed ID: 10745070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
    Rahimy MH; Ryan KK; Hopkins NK
    Contraception; 1999 Oct; 60(4):209-14. PubMed ID: 10640167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dienogest on estrogen-induced nitric oxide production in human umbilical vein endothelial cells and endothelium-dependent vasodilatation in postmenopausal women.
    Henmi N; Takahashi K; Amita M; Takata K; Ohta T; Tsutsumi S; Takahashi T; Kurachi H
    Menopause; 2010; 17(3):615-21. PubMed ID: 20386344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
    Rahimy MH; Cromie MA; Hopkins NK; Tong DM
    Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group.
    Kaunitz AM; Garceau RJ; Cromie MA
    Contraception; 1999 Oct; 60(4):179-87. PubMed ID: 10640164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
    Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
    Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.